On June 2020, 6 (Wednesday), Kyowa Pharmaceutical Industry Co., Ltd. and FRONTEO held a press conference on "Business Alliance for Development and Sales of New Medical Devices to Support Dementia Diagnosis" using AI. It was.

Dementia diagnosis support AI system is FRONTEO's original natural language analysis AI "concept encoderIt is a system that can judge the presence or absence of cognitive dysfunction from a conversation between a patient and a doctor for about 5 to 10 minutes.

In Japan, which is expected to enter a super-aging society for a long time in the future, dementia countermeasures are becoming a national issue, and we can support the diagnosis of dementia through natural conversations rather than specialized conversations and interviews. This system can be expected to provide the following benefits to both medical professionals and patients.

1. Reducing the physical and psychological burden on both the patient and the healthcare professional

2. Early detection of dementia and efficiency of medical care

3. Advances in digital medical care including telemedicine

We would like to take this opportunity to thank all the media for their participation in the presentation using Zoom as a preventive measure against new coronavirus infections.

Details of the announcement will be delivered on the same day.Press release .

To apply for an interview / interviewplease use this form.